These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 11755958
21. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. Rezaie AR, Cooper ST, Church FC, Esmon CT. J Biol Chem; 1995 Oct 27; 270(43):25336-9. PubMed ID: 7592694 [Abstract] [Full Text] [Related]
23. Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin. Rezaie AR, Yang L. Proc Natl Acad Sci U S A; 2003 Oct 14; 100(21):12051-6. PubMed ID: 14523228 [Abstract] [Full Text] [Related]
25. The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation. Incampo F, Carrieri C, Semeraro N, Colucci M. Thromb Res; 2014 Nov 14; 134(5):1110-6. PubMed ID: 25193406 [Abstract] [Full Text] [Related]
27. Calcium-dependent activation of protein C by thrombin/thrombomudulin: role of negatively charged amino acids within the activation peptide of protein C. Friedrich U, Pötzsch B, Preissner KT, Müller-Berghaus G, Ehrlich H. Thromb Haemost; 1994 Oct 14; 72(4):567-72. PubMed ID: 7878634 [Abstract] [Full Text] [Related]
28. Interaction of thrombin des-ETW with antithrombin III, the Kunitz inhibitors, thrombomodulin and protein C. Structural link between the autolysis loop and the Tyr-Pro-Pro-Trp insertion of thrombin. Le Bonniec BF, Guinto ER, Esmon CT. J Biol Chem; 1992 Sep 25; 267(27):19341-8. PubMed ID: 1326550 [Abstract] [Full Text] [Related]
29. Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition. Côté HC, Bajzar L, Stevens WK, Samis JA, Morser J, MacGillivray RT, Nesheim ME. J Biol Chem; 1997 Mar 07; 272(10):6194-200. PubMed ID: 9045633 [Abstract] [Full Text] [Related]
34. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III. Koyama T, Parkinson JF, Sié P, Bang NU, Müller-Berghaus G, Preissner KT. Eur J Biochem; 1991 Jun 15; 198(3):563-70. PubMed ID: 1646716 [Abstract] [Full Text] [Related]
35. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains. Hall SW, Nagashima M, Zhao L, Morser J, Leung LL. J Biol Chem; 1999 Sep 03; 274(36):25510-6. PubMed ID: 10464282 [Abstract] [Full Text] [Related]
38. Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulin. Horie S, Ishii H, Hara H, Kazama M. Biochem J; 1994 Aug 01; 301 ( Pt 3)(Pt 3):683-91. PubMed ID: 8053894 [Abstract] [Full Text] [Related]
39. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Hofsteenge J, Taguchi H, Stone SR. Biochem J; 1986 Jul 01; 237(1):243-51. PubMed ID: 3026312 [Abstract] [Full Text] [Related]
40. Platelet factor 4 stimulates thrombomodulin protein C-activating cofactor activity. A structure-function analysis. Slungaard A, Key NS. J Biol Chem; 1994 Oct 14; 269(41):25549-56. PubMed ID: 7523387 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]